Hyaluronic acid (HA) fillers are among the most popular non-surgical cosmetic treatments in the world, with millions of procedures performed every year to smooth wrinkles, restore volume, and contour the face. They are widely regarded as safe, biocompatible, and reversible. But since the start of the COVID-19 pandemic, both patients and aesthetic practitioners have noticed something unusual: some people who have had hyaluronic acid fillers develop swelling or redness at the injection site days or weeks after catching COVID-19 or receiving a COVID-19 vaccine. This article explains what HA fillers are, the common and rare side effects, why COVID can trigger reactions, and what you can do about them.
What Are Hyaluronic Acid Fillers?
Hyaluronic acid is a naturally occurring glycosaminoglycan found throughout the body, in skin, joints, and connective tissue. It holds water and keeps skin plump, smooth, and hydrated. In dermal fillers, HA is injected beneath the skin to restore lost volume, soften lines, and enhance features such as the lips, cheeks, tear troughs, and jawline.
Because HA is biologically identical in all organisms and contains no protein epitopes, it is considered immunologically inert, which means the risk of an allergic reaction is very low. Most HA fillers are broken down naturally by the body over time, usually lasting from several months to a year or more depending on the product and the treatment area.
Common Side Effects of Hyaluronic Acid Fillers
Most side effects are mild, temporary, and related to the injection itself:
- Swelling and bruising at the injection site
- Redness and tenderness
- Small bumps or lumps that usually settle within a few days
- Itching or a feeling of tightness
These reactions typically resolve within a few days to a week and can be minimized with ice packs, avoiding blood-thinning medication, and following the practitioner's aftercare advice.
Serious complications are rare. They include infection, vascular occlusion (when filler blocks a blood vessel), and allergic reactions. Choosing a qualified, experienced practitioner and using high-quality products significantly reduces these risks.
Delayed Inflammatory Reactions: The Rare Side Effect Linked to COVID
The side effect that has attracted the most attention during the pandemic is the delayed inflammatory reaction (DIR). Unlike immediate reactions, DIRs appear weeks, months, or even more than a year after the filler was injected.
Clinically, a DIR looks like:
- Swelling or puffiness at the site where filler was placed
- Redness and warmth
- Tenderness or pain
- Hardening of the tissue or tender nodules
These reactions are not caused by the filler itself being "bad." They are thought to be a type IV delayed hypersensitivity reaction driven by T-lymphocytes. The immune system, already busy fighting a viral infection or responding to a vaccine, becomes activated and, in some people, this triggers inflammation around the filler.
This phenomenon is not new. Delayed reactions to HA fillers were reported long before COVID-19, often after a flu-like illness or an influenza vaccination. What changed with the pandemic is the scale: millions of people were infected with or vaccinated against SARS-CoV-2, so these uncommon reactions became much more visible.
Why Does COVID Trigger Filler Reactions?
Researchers believe several mechanisms are involved. SARS-CoV-2 enters cells through the ACE2 receptor, which is abundant in the skin, particularly in fibroblasts, keratinocytes, and the fatty tissue where fillers are often placed. The virus and the vaccine both trigger a strong immune and inflammatory response.
In addition, high-molecular-weight HA is anti-inflammatory, but when HA breaks down into low-molecular-weight fragments, those fragments become pro-inflammatory and can activate immune cells through the CD44 receptor. A systemic infection or vaccination may accelerate this breakdown, leading to inflammation around the filler.
It is important to emphasize that these reactions are uncommon, usually mild, and almost always self-limiting. In most reported cases, the swelling settles on its own within days.
How Are These Reactions Treated?
If you develop swelling at a previous filler site after COVID-19 or vaccination, contact your practitioner. In most cases, no treatment is needed and the reaction resolves spontaneously. When treatment is required, options include:
- Oral corticosteroids to reduce inflammation
- Hyaluronidase, an enzyme that dissolves hyaluronic acid filler quickly
- Antibiotics if a bacterial infection is suspected
Some specialists have also explored ACE-inhibitor medications, such as lisinopril, based on the theory that they may reduce the inflammatory pathway involved. Always follow the advice of a qualified medical professional.
Prevention Tips
- If you are planning filler treatment, discuss your vaccination schedule with your practitioner. Some experts suggest leaving a gap of a few weeks between vaccination and filler injections.
- Choose a reputable clinic and an experienced injector.
- Use high-quality, well-characterized hyaluronic acid products.
- Keep records of your treatments, including the product used and injection sites, so reactions can be identified quickly.
- Report any unusual swelling to your practitioner promptly, even if it seems mild.
The Bottom Line
Hyaluronic acid injections remain one of the safest and most popular options for facial rejuvenation. The delayed reactions occasionally seen after COVID-19 infection or vaccination are uncommon, generally mild, and typically resolve without any treatment. If you have any concerns, speak with your practitioner; they can reassure you, monitor the area, and treat the reaction if necessary.
For manufacturers and formulators looking for high-quality hyaluronic acid raw materials, choosing a reliable supplier with rigorous quality control is essential. Cactus Botanics is a global natural-ingredient manufacturer that supplies hyaluronic acid and a wide range of botanical extracts and nutraceutical ingredients, backed by GMP-compliant production and comprehensive analytical testing.
